Announcement of Jiangsu Hengrui Pharmaceuticals Obtaining Notification of Drug Clinical Trial Approval
Jiangsu Hengrui Pharmaceuticals: Announcement of Jiangsu Hengrui Pharmaceuticals Obtaining Notification of Drug Clinical Trial Approval
Jiangsu Hengrui Pharmaceuticals: Announcement of Jiangsu Hengrui Pharmaceuticals Obtaining Notification of Drug Clinical Trial Approval
Announcement of Jiangsu Hengrui Pharmaceuticals Obtaining Notification of Drug Clinical Trial Approval
Announcement of Jiangsu Hengrui Pharmaceuticals Obtaining Notification of Drug Clinical Trial Approval
Legal opinion on differentiated dividends of Jiangsu Hengrui Pharmaceuticals.
Jiangsu Hengrui Pharmaceuticals Announcement Regarding Obtaining FDA Approval Number in USA
Announcement of jiangsu hengrui pharmaceuticals on obtaining pharmaceutical registration certificate.
Announcement of Jiangsu Hengrui Pharmaceuticals Obtaining Notification of Drug Clinical Trial Approval
Hengrui Pharmaceutical's Announcement on Obtaining Approval Notice for Drug Clinical Trials
Hengrui Pharmaceutical's announcement on obtaining a drug registration certificate
Announcement of Resolutions of the 8th Meeting of the 9th Board of Directors of Hengrui Pharmaceutical
Hengrui Pharmaceutical's Announcement on Obtaining Approval Notice for Drug Clinical Trials
Hengrui Pharmaceutical's Announcement on the Company's Drug Obtaining Fast Track Qualification from the US FDA
Hengrui Pharmaceutical's Announcement on Holding Results Briefings for the First Quarter of 2023 and 2024
Announcement of Resolutions of the 7th Meeting of the 9th Board of Directors of Hengrui Pharmaceutical
Hengrui Pharmaceutical Independent Director Work System
Hengrui Pharmaceutical 2023 Audit Report
Special note on the 2023 non-operating capital occupation and other related capital transactions of Jiangsu Hengrui Pharmaceutical Co., Ltd.
Hengrui Pharmaceutical 2023 Independent Director Debriefing Report (Zeng Qingsheng)
No Data